Study links semaglutide and tirzepatide to fewer anxiety and depression diagnoses in obesity care
A US electronic health record study found that adults with obesity who started semaglutide or tirzepatide had lower recorded hazards of anxiety and depression than matched patients using naltrexone-bupropion. However,…